{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:42:58Z","timestamp":1790962978655,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It remains a significant challenge to overcome the poor permeability of cyclosporine A and enhance its oral absorption. In this study, we have identified a positively charged chitosan that is able to induce coiling up of anionic lipids to form nanocochleates with an average size of 114.2\u2009\u00b1\u20090.8\u2009nm, without the need for calcium ions. These functional chitosan-induced nanocochleates enhanced gastrointestinal absorption of cyclosporine A, up to a 3-fold increase in oral bioavailability. A fluorescence-labeling study confirmed that absorption mainly occurred in the duodenum and jejunum. Transport studies indicated that uptake of chitosan-induced nanocochleates by Caco-2 cells was by clathrin- and caveolae-mediated endocytosis, but not by macropinocytosis. Furthermore, three cellular tight junction proteins, ZO-1, F-actin and claudin-4, were significantly down-regulated, suggesting that chitobiose-induced nanocochleates are able to reconstruct and open tight junctions in intestinal epithelial cells to enhance drug absorption. In summary, these novel bifunctional chitosan-induced nanocochleates appear to have potential to facilitate oral delivery of cyclosporine A.<\/jats:p>","DOI":"10.1038\/srep41322","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T07:08:58Z","timestamp":1485155338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Chitosan functionalized nanocochleates for enhanced oral absorption of cyclosporine A"],"prefix":"10.1038","volume":"7","author":[{"given":"Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,23]]},"reference":[{"key":"BFsrep41322_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/med.20217","volume":"32","author":"R Paliwal","year":"2012","unstructured":"Paliwal, R., Paliwal, S. R., Agrawal, G. P. & Vyas, S. P. Recent advances in search of oral heparin therapeutics. Med. Res. Rev. 32, 388\u2013409 (2012).","journal-title":"Med. Res. Rev"},{"key":"BFsrep41322_CR2","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ijpharm.2016.07.041","volume":"511","author":"AK Granath","year":"2016","unstructured":"Granath, A. K. & Sigfridsson, K. Evaluation of preclinical formulations for a poorly water-soluble compound. Int. J. Pharm. 511, 630\u2013637 (2016).","journal-title":"Int. J. Pharm"},{"key":"BFsrep41322_CR3","first-page":"30315","volume":"16","author":"S Khan","year":"2016","unstructured":"Khan, S., Shaharyar, M., Fazil, M., Baboota, S. & Ali, J. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization. Eur. J. Pharm. Biopharm. 16, 30315\u20130 (2016).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"BFsrep41322_CR4","first-page":"231","volume":"6","author":"CJ Porter","year":"2007","unstructured":"Porter, C. J., Trevaskis, N. L. & Charman, W. N. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. 6, 231\u2013248 (2007).","journal-title":"Nat. Rev"},{"key":"BFsrep41322_CR5","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1039\/C5SM01469G","volume":"12","author":"K Nagarsekar","year":"2016","unstructured":"Nagarsekar, K. et al. Understanding cochleate formation: insights into structural development. Soft matter 12, 3797\u20133809 (2016).","journal-title":"Soft matter"},{"key":"BFsrep41322_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/la504428x","volume":"31","author":"T Bozo","year":"2015","unstructured":"Bozo, T., Brecska, R., Grof, P. & Kellermayer, M. S. Extreme resilience in cochleate nanoparticles. Langmuir. 31, 839\u2013845 (2015).","journal-title":"Langmuir"},{"key":"BFsrep41322_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1517\/17425247.2013.860131","volume":"11","author":"C Bothiraja","year":"2014","unstructured":"Bothiraja, C., Yojana, B. D., Pawar, A. P., Shaikh, K. S. & Thorat, U. H. Fisetin-loaded nanocochleates: formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study. Expert. Opin. Drug. Deliv. 11, 17\u201329 (2014).","journal-title":"Expert. Opin. Drug. Deliv"},{"key":"BFsrep41322_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1517\/17425240902802861","volume":"6","author":"SJ Thornton","year":"2009","unstructured":"Thornton, S. J. & Wasan, K. M. The reformulation of amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis. Expert. Opin. Drug. Deliv. 6, 271\u2013284 (2009).","journal-title":"Expert. Opin. Drug. Deliv"},{"key":"BFsrep41322_CR9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jconrel.2013.10.011","volume":"172","author":"K Gradauer","year":"2013","unstructured":"Gradauer, K. et al. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats. J. Control. Release. 172, 872\u2013878 (2013).","journal-title":"J. Control. Release"},{"key":"BFsrep41322_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jconrel.2006.11.002","volume":"117","author":"M Thanou","year":"2007","unstructured":"Thanou, M., Henderson, S., Kydonieus, A. & Elson, C. N-sulfonato-N, O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules. J. Control. Release. 117, 171\u2013178 (2007).","journal-title":"J. Control. Release"},{"key":"BFsrep41322_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jconrel.2009.08.014","volume":"140","author":"E Lee","year":"2009","unstructured":"Lee, E., Kim, H., Lee, I. H. & Jon, S. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. J. Control. Release. 140, 79\u201385 (2009).","journal-title":"J. Control. Release"},{"key":"BFsrep41322_CR12","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1128\/AAC.44.6.1463-1469.2000","volume":"44","author":"L Zarif","year":"2000","unstructured":"Zarif, L. et al. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Antimicrob. Agents. Chemother. 44, 1463\u20131469 (2000).","journal-title":"Antimicrob. Agents. Chemother"},{"key":"BFsrep41322_CR13","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1128\/AAC.44.9.2356-2360.2000","volume":"44","author":"R Santangelo","year":"2000","unstructured":"Santangelo, R. et al. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob. Agents. Chemother. 44, 2356\u20132360 (2000).","journal-title":"Antimicrob. Agents. Chemother"},{"key":"BFsrep41322_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v24.i1.20","volume":"24","author":"R Rao","year":"2007","unstructured":"Rao, R., Squillante, E. 3rd & Kim, K. H. Lipid-based cochleates: a promising formulation platform for oral and parenteral delivery of therapeutic agents. Crit. Rev. Ther. Drug. Carrier. Syst. 24, 41\u201361 (2007).","journal-title":"Crit. Rev. Ther. Drug. Carrier. Syst"},{"key":"BFsrep41322_CR15","first-page":"198","volume":"5","author":"DS Perlin","year":"2004","unstructured":"Perlin, D. S. Amphotericin B cochleates: a vehicle for oral delivery. Curr. Opin. Investig. Drugs. 5, 198\u2013201 (2004).","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"BFsrep41322_CR16","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1096\/fj.10-167809","volume":"24","author":"L Livne","year":"2010","unstructured":"Livne, L., Epand, R. F., Papahadjopoulos-Sternberg, B., Epand, R. M. & Mor, A. OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria. FASEB. J. 24, 5092\u20135101 (2010).","journal-title":"FASEB. J"},{"key":"BFsrep41322_CR17","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1096\/fj.11-183764","volume":"25","author":"H Sarig","year":"2011","unstructured":"Sarig, H., Ohana, D., Epand, R. F., Mor, A. & Epand, R. M. Functional studies of cochleate assemblies of an oligo-acyl-lysyl with lipid mixtures for combating bacterial multidrug resistance. FASEB. J. 25, 3336\u20133343 (2011).","journal-title":"FASEB. J"},{"key":"BFsrep41322_CR18","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1021\/jp111242q","volume":"115","author":"RF Epand","year":"2011","unstructured":"Epand, R. F. et al. Physical properties affecting cochleate formation and morphology using antimicrobial oligo-acyl-lysyl peptide mimetics and mixtures mimicking the composition of bacterial membranes in the absence of divalent cations. J. Phys. Chem. B. 115, 2287\u20132293 (2011).","journal-title":"J. Phys. Chem. B"},{"key":"BFsrep41322_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/md14050099","volume":"5","author":"B Bellich","year":"2016","unstructured":"Bellich B. et al. \u201cThe Good, the Bad and the Ugly\u201d of Chitosans. Mar. Drugs. 5, 99 (2016).","journal-title":"Mar. Drugs"},{"key":"BFsrep41322_CR20","first-page":"10142","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang Y. et al. High-Performance Capacitive Deionization Disinfection of Water with Graphene Oxide-graft-Quaternized Chitosan Nanohybrid Electrode Coating. ACS. Nano. 10, 10142\u201357 (2015).","journal-title":"ACS. Nano"},{"key":"BFsrep41322_CR21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.biomaterials.2012.09.082","volume":"34","author":"LW Hsu","year":"2013","unstructured":"Hsu, L. W. et al. Effects of pH on molecular mechanisms of chitosan-integrin interactions and resulting tight-junction disruptions. Biomaterials. 34, 784\u2013793 (2013).","journal-title":"Biomaterials"},{"key":"BFsrep41322_CR22","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1021\/mp400282r","volume":"10","author":"H Lian","year":"2013","unstructured":"Lian, H. et al. Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism. Mol. Pharm. 10, 3447\u20133458 (2013).","journal-title":"Mol. Pharm"},{"key":"BFsrep41322_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2016.04.012","volume":"232","author":"M Lopes","year":"2016","unstructured":"Lopes, M. et al. Dual chitosan\/albumin-coated alginate\/dextran sulfate nanoparticles for enhanced oral delivery of insulin. J. Control. Release. 232, 29\u201341 (2016).","journal-title":"J. Control. Release"},{"key":"BFsrep41322_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1021\/bm0607776","volume":"8","author":"YH Lin","year":"2007","unstructured":"Lin, Y. H. et al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules. 8, 146\u2013152 (2007).","journal-title":"Biomacromolecules"},{"key":"BFsrep41322_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1021\/mp200479f","volume":"9","author":"M Vertzoni","year":"2012","unstructured":"Vertzoni, M. et al. Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers. Mol. Pharm. 9, 1189\u20131198 (2012).","journal-title":"Mol. Pharm"},{"key":"BFsrep41322_CR26","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1021\/mp200400s","volume":"9","author":"S Meng","year":"2012","unstructured":"Meng, S. et al. SULT1A3-mediated regiospecific 7-O-sulfation of flavonoids in Caco-2 cells can be explained by the relevant molecular docking studies. Mol. Pharm. 9, 862\u2013873 (2012).","journal-title":"Mol. Pharm"},{"key":"BFsrep41322_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jamcollsurg.2015.12.006","volume":"222","author":"W Liu","year":"2016","unstructured":"Liu, W. et al. Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels. J. Am. Col. l Surg. 222, 1009\u20131017 (2016).","journal-title":"J. Am. Col. l Surg."},{"key":"BFsrep41322_CR28","doi-asserted-by":"publisher","first-page":"28589","DOI":"10.1038\/srep28589","volume":"6","author":"Y Gao","year":"2016","unstructured":"Gao, Y., Lui, W. Y., Lee, W. M. & Cheng, C. Y. Polarity protein Crumbs homolog-3 (CRB3) regulates ectoplasmic specialization dynamics through its action on F-actin organization in Sertoli cells. Sci. Rep. 6, 28589 (2016).","journal-title":"Sci. Rep"},{"key":"BFsrep41322_CR29","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.xphs.2015.11.018","volume":"105","author":"A Bocsik","year":"2016","unstructured":"Bocsik, A. et al. Reversible Opening of Intercellular Junctions of Intestinal Epithelial and Brain Endothelial Cells With Tight Junction Modulator Peptides. J. Pharm. Sci. 105, 754\u2013765 (2016).","journal-title":"J. Pharm. Sci."},{"key":"BFsrep41322_CR30","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1021\/mp200572t","volume":"9","author":"K Sonaje","year":"2012","unstructured":"Sonaje, K. et al. Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations. Mol. Pharm. 9, 1271\u20131279 (2012).","journal-title":"Mol. Pharm"},{"key":"BFsrep41322_CR31","doi-asserted-by":"publisher","first-page":"8712","DOI":"10.1016\/j.biomaterials.2011.07.086","volume":"32","author":"K Sonaje","year":"2011","unstructured":"Sonaje, K. et al. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins. Biomaterials. 32, 8712\u20138721 (2011).","journal-title":"Biomaterials"},{"key":"BFsrep41322_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jconrel.2003.05.001","volume":"93","author":"A Bernkop-Schnurch","year":"2003","unstructured":"Bernkop-Schnurch, A., Kast, C. E. & Guggi, D. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer\/GSH systems. J. Control. Release. 93, 95\u2013103 (2003).","journal-title":"J. Control. Release"}],"updated-by":[{"DOI":"10.1038\/s41598-019-41386-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep41322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep41322","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep41322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T19:40:47Z","timestamp":1671824447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep41322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,23]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,2,20]]}},"alternative-id":["BFsrep41322"],"URL":"https:\/\/doi.org\/10.1038\/srep41322","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-019-41386-9","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,23]]},"assertion":[{"value":"6 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41322"}}